Novo’s Frehemgo Expected Launch In Europe Q4 2026, EU-Wide Seen Early-2027
Story updates
02:32:59 PM UTC
SquawkNews
By Adria CalatayudNovo Nordisk said a key European Medicines Agency committee recommended the approval of its Frehemgo drug for hemophilia A.The Danish drugmaker said Thursday that it expects to launch the medicine in the first European countries in the fourth quarter, and more broadly across the E…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.